Board Recommended final dividend of Re.0.60/- per equity shares of face value of Re.1/- each
SHILPAMED · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Shilpa Medicare's Board has recommended a final dividend of ₹0.60 per equity share (60% payout on ₹1 face value) for FY 2025-26, subject to shareholder approval at the AGM. The company reported strong financial performance with standalone net profit jumping 96% year-on-year to ₹13,297 lakhs, while consolidated net profit rose 211% to ₹24,333 lakhs. Consolidated revenue from operations grew 20% to ₹1,53,887 lakhs. The paid-up share capital doubled from ₹978 lakhs to ₹1,956 lakhs compared to the previous year, indicating a 1:1 bonus issue was completed. The company also announced plans to shift its registered office from Karnataka to Maharashtra and acquire a 28% stake in Neo Green Power Project Private Limited for ₹4.44 crore to meet captive power requirements.
The dividend maintains a 60% payout ratio consistent with prior year, signalling management confidence in sustained earnings growth. The near-doubling of net profit provides strong fundamental support for the stock. However, the absolute dividend amount remains modest at ₹0.60 per share.